WhichRecall
Class IIReported 2025-04-30

clomiPRAMINE hydrochloride Capsules USP, 25 mg, 100-count bottle, Rx only, Manufactured For: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, United States, Manufactured By: Lupin Limited, Nagpur, 441 108 INDIA, NDC 68180-492-01

Recalled by Lupin Pharmaceuticals Inc.

Reason for Recall

Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.

Advertisement
Recall Number
D-0377-2025
Classification
Class II
Status
Terminated
Category
drug
Initiated
2025-04-10
Reported
2025-04-30
Distribution
USA nationwide
Code Info
Lot #: M300442, Exp Date: 6/30/2025
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement